1. Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus. Issue 12 (9th October 2017) Authors: Grammes, J.; Stock, W.; Mann, C. G.; Flynn, E. M.; Kubiak, T. Journal: Diabetic medicine Issue: Volume 34:Issue 12(2017) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY DIAGNOSED NPM1-MUTATED AML. (23rd June 2022) Authors: Byrd, J. C.; Cortes, J. E.; Minden, M. D.; Oellerich, T.; Stein, E. M.; Elder, J.; Kumar, P.; Bray, G.; DiMartino, J.; Stock, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML). (April 2017) Authors: Savona, M.R.; Garcia-Manero, G.; Roboz, G.J.; Walsh, K.J.; Kropf, P.L.; Issa, J.P.; O'Connell, C.L.; Tibes, R.; Yee, K.W.L.; Stock, W.; Lunin, S.; Berdeja, J.G.; Naim, S.; Hao, Y.; Azab, M.; Kantarjian, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TARGETING RNA EPIGENETICS TO PREDICT AND OVERCOME DRUG RESISTANCE IN MDS AND AML. (May 2023) Authors: Cheng, J.; Wood, S.; Willbanks, A.; Tang, D.; Degenstein, L.; Arber, D.; Oakes, S.; Shammo, J.; Odenike, T.; Stock, W.; Larson, R.; Joachimiak, A.; Stevens, R. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗